Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/14 申報。只含多頭部位，變化是跟 2022 年第 3 季比股數。
- 持股檔數
- 57
- 較 2022 年第 3 季 −3
- 總值
- $22.9 億
- 較 2022 年第 3 季 +$2.70 億 (+13.3%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| IMVTImmunovant, Inc. | COM | 9,710,000 | $1.72 億 | 7.5% | −150,246−1.5% | 減碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 7,878,119 | $1.69 億 | 7.4% | +878,119+12.5% | 加碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 873,553 | $1.39 億 | 6.1% | +12,553+1.5% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 4,582,000 | $9,636 萬 | 4.2% | +582,000+14.5% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 700,000 | $8,549 萬 | 3.7% | −100,000−12.5% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 4,264,292 | $8,520 萬 | 3.7% | +4,264,292 | 新進 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 2,819,045 | $8,344 萬 | 3.6% | −80,955−2.8% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,187,415 | $8,329 萬 | 3.6% | +358,321+12.7% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 300,000 | $8,308 萬 | 3.6% | +300,000 | 新進 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,109,886 | $8,089 萬 | 3.5% | +740,676+31.3% | 加碼 | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 3,000,000 | $7,860 萬 | 3.4% | 00.0% | 不變 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 528,244 | $6,845 萬 | 3.0% | +528,244 | 新進 | 歷史 |
| AGENAgenus Inc | COM NEW | 27,000,000 | $6,480 萬 | 2.8% | +675,000+2.6% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,656,901 | $5,901 萬 | 2.6% | −539,741−16.9% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 500,000 | $5,690 萬 | 2.5% | −962,800−65.8% | 減碼 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 1,734,143 | $5,411 萬 | 2.4% | +734,143+73.4% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,771,154 | $5,174 萬 | 2.3% | −199,136−10.1% | 減碼 | 歷史 |
| ETNB89bio, Inc. | COM | 3,850,000 | $4,901 萬 | 2.1% | +1,214,000+46.1% | 加碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,166,473 | $4,562 萬 | 2.0% | +166,473+16.6% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 1,205,773 | $4,554 萬 | 2.0% | +1,205,773 | 新進 | 歷史 |
| ALLKAllakos Inc. | COM | 4,899,179 | $4,125 萬 | 1.8% | +380,604+8.4% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 2,727,606 | $4,012 萬 | 1.7% | −400,061−12.8% | 減碼 | 歷史 |
| ALBOAlbireo Pharma, Inc. | COM | 1,704,000 | $3,682 萬 | 1.6% | +593,376+53.4% | 加碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 1,732,946 | $3,350 萬 | 1.5% | +333,202+23.8% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,684,200 | $3,111 萬 | 1.4% | −500,000−15.7% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 3,374,394 | $3,017 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,951,580 | $2,976 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,000,000 | $2,850 萬 | 1.2% | +15,000,000 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,816,531 | $2,705 萬 | 1.2% | +1,816,531 | 新進 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 2,104,174 | $2,630 萬 | 1.1% | −259,014−11.0% | 減碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,304,940 | $2,584 萬 | 1.1% | +1,304,940 | 新進 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 4,000,000 | $2,492 萬 | 1.1% | −1,636,587−29.0% | 減碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,266,569 | $2,489 萬 | 1.1% | +212,948+10.4% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 2,327,951 | $2,477 萬 | 1.1% | +2,327,951 | 新進 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 700,000 | $2,442 萬 | 1.1% | +400,000+133.3% | 加碼 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 3,952,000 | $2,134 萬 | 0.9% | +173,182+4.6% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 189,800 | $1,964 萬 | 0.9% | −549,063−74.3% | 減碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,048,829 | $1,919 萬 | 0.8% | −4,171−0.4% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 7,414,693 | $1,794 萬 | 0.8% | +7,414,693 | 新進 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 6,496,976 | $1,624 萬 | 0.7% | −2,051,411−24.0% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 8,221,188 | $1,578 萬 | 0.7% | −1,104,352−11.8% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 500,000 | $1,273 萬 | 0.6% | +500,000 | 新進 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,837,818 | $990.4 萬 | 0.4% | +2,376,957+515.8% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 871,493 | $950.8 萬 | 0.4% | +871,493 | 新進 | 歷史 |
| NKTXNkarta, Inc. | COM | 1,354,200 | $811.2 萬 | 0.4% | −1,460,644−51.9% | 減碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 300,000 | $665.7 萬 | 0.3% | +300,000 | 新進 | – |
| VKTXViking Therapeutics, Inc. | COM | 610,083 | $573.5 萬 | 0.2% | +610,083 | 新進 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 768,607 | $559.5 萬 | 0.2% | −132,104−14.7% | 減碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $485.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| JNCEJounce Therapeutics, Inc. | COM | 4,259,653 | $472.8 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 695,845 | $357.0 萬 | 0.2% | −228,796−24.7% | 減碼 | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 3,250,000 | $341.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ASMBAssembly Biosciences, Inc. | COM | 1,833,437 | $238.3 萬 | 0.1% | −1,166,563−38.9% | 減碼 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 445,572 | $191.6 萬 | 0.1% | −822,648−64.9% | 減碼 | 歷史 |
| AUPHAurinia Pharmaceuticals Inc. | COM | 324,238 | $140.1 萬 | 0.1% | −5,353,134−94.3% | 減碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 3,000,000 | $118.5 萬 | 0.1% | −2,359,000−44.0% | 減碼 | 歷史 |
| HOOKHOOKIPA Pharma Inc. | COM | 1,240,369 | $100.5 萬 | <0.1% | −3,795,629−75.4% | 減碼 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2022 年第 3 季之後清倉（16 檔）
2022 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 3 季股數 | 2022 年第 3 季市值 | 2022 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| NVCRNovoCure Ltd | ORD SHS | 1,293,761 | $9,830 萬 | 4.9% | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,186,083 | $4,352 萬 | 2.2% | 歷史 |
| FATEFate Therapeutics Inc | COM | 1,311,113 | $2,938 萬 | 1.5% | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 790,926 | $2,693 萬 | 1.3% | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 775,000 | $2,662 萬 | 1.3% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,824,000 | $2,647 萬 | 1.3% | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 326,600 | $2,224 萬 | 1.1% | 歷史 |
| FMTXForma Therapeutics Holdings, Inc. | SHS | 966,573 | $1,928 萬 | 1.0% | 歷史 |
| ARDXArdelyx, Inc. | COM | 14,858,000 | $1,768 萬 | 0.9% | 歷史 |
| TCDATricida, Inc. | COM | 1,177,680 | $1,234 萬 | 0.6% | 歷史 |
| ACETAdicet Bio, Inc. | COM | 825,508 | $1,174 萬 | 0.6% | 歷史 |
| KROSKeros Therapeutics, Inc. | COM | 248,500 | $934.9 萬 | 0.5% | 歷史 |
| ANABAnaptysbio, Inc | COM | 360,000 | $918.4 萬 | 0.5% | 歷史 |
| SDGRSchrodinger, Inc. | COM | 170,000 | $424.7 萬 | 0.2% | 歷史 |
| PASGPassage BIO, Inc. | COM | 1,439,062 | $179.9 萬 | 0.1% | 歷史 |
| GRTSGritstone bio, Inc. | COM | 45,500 | $11.7 萬 | <0.1% | 歷史 |